跳至主導覽 跳至搜尋 跳過主要內容

ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells

  • Chung Pu Wu*
  • , Cheng Yu Hung
  • , Megumi Murakami
  • , Yu Shan Wu
  • , Yi Hsuan Chu
  • , Yang Hui Huang
  • , Jau Song Yu
  • , Suresh V. Ambudkar
  • *此作品的通信作者
  • Chang Gung Memorial Hospital
  • Chang Gung University
  • National Institutes of Health
  • Tunghai University

研究成果: 期刊稿件 › 文章 › 同儕審查

3 引文 斯高帕斯(Scopus)

摘要

MTX-211 is a first-in-class dual inhibitor of epidermal growth factor receptor (EGFR) and phosphoinositide-3 kinase (PI3K) signaling pathways with a compelling pharmaceutical profile and could enhance the effectiveness of mitogen-activated protein kinase kinase (MEK) inhibitor therapy in colorectal tumors with KRAS mutations. However, the specific mechanisms contributing to the acquired resistance to MTX-211 in human cancers remain elusive. Here, we discovered that the overexpression of the ATP-binding cassette (ABC) drug transporter ABCG2, a prevalent mechanism associated with multidrug resistance (MDR), could diminish the effectiveness of MTX-211 in human cancer cells. We showed that the drug efflux activity of ABCG2 substantially decreased the intracellular accumulation of MTX-211 in cancer cells. As a result, the cytotoxicity and effectiveness of MTX-211 in suppressing the activation of the EGFR and PI3K pathways were significantly attenuated in cancer cells overexpressing ABCG2. Moreover, the enhancement of the MTX-211-stimulated ATPase activity of ABCG2 and the computational molecular docking analysis illustrating the binding of MTX-211 to the substrate-binding sites of ABCG2 offered a further indication for the interaction between MTX-211 and ABCG2. In summary, our findings indicate that MTX-211 acts as a substrate for ABCG2, underscoring the involvement of ABCG2 in the emergence of resistance to MTX-211. This finding carries clinical implications and merits further exploration.

原文英語
文章編號5160
期刊International Journal of Molecular Sciences
卷25
發行號10
DOIs
出版品狀態已出版 - 09 05 2024

文獻附註

Publisher Copyright:
© 2024 by the authors.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells」主題。共同形成了獨特的指紋。

引用此